ABERCROMBIE GEORGE B 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Apr 20, 2022
Insider Transaction Report
Form 4
ABERCROMBIE GEORGE B
Director
Transactions
- Sale
Common Stock
2022-04-18$11.04/sh−5,000$55,200→ 0 total - Exercise/Conversion
Common Stock
2022-04-18$3.32/sh+5,000$16,600→ 5,000 total - Exercise/Conversion
Automatic Stock Option Grant
2022-04-18−5,000→ 0 totalExercise: $3.32Exp: 2022-05-23→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
- [F2]The option vested 1/12 per month for a period of 12 months, beginning on June 23, 2012.